Preface, |
|
xiii | |
Acknowledgements, |
|
xv | |
List of Abbreviations, |
|
xvii | |
About the Companion Website, |
|
xxi | |
1 Introduction to Blood Science, |
|
1 | (24) |
|
1.1 What is blood science?, |
|
|
1 | (5) |
|
|
6 | (2) |
|
|
8 | (2) |
|
|
10 | (4) |
|
|
14 | (3) |
|
|
17 | (2) |
|
1.7 The role of blood science in modern healthcare, |
|
|
19 | (3) |
|
1.8 What this book will achieve, |
|
|
22 | (1) |
|
|
23 | (1) |
|
|
23 | (1) |
|
|
23 | (1) |
|
|
23 | (2) |
2 Analytical Techniques in Blood Science, |
|
25 | (26) |
|
|
25 | (1) |
|
|
26 | (1) |
|
2.3 Sample identification and tracking, |
|
|
27 | (1) |
|
2.4 Technical and analytical confidence, |
|
|
27 | (5) |
|
|
32 | (11) |
|
|
43 | (4) |
|
2.7 Point of care testing, |
|
|
47 | (1) |
|
2.8 Health and safety in the laboratory, |
|
|
48 | (1) |
|
|
49 | (1) |
|
|
50 | (1) |
|
|
50 | (1) |
3 The Physiology of the Red Blood Cell, |
|
51 | (24) |
|
|
51 | (1) |
|
3.2 The development of blood cells, |
|
|
52 | (4) |
|
|
56 | (2) |
|
3.4 The red cell membrane, |
|
|
58 | (2) |
|
3.5 The cytoplasm of the red cell, |
|
|
60 | (6) |
|
|
66 | (2) |
|
3.7 Recycling the red cell, |
|
|
68 | (1) |
|
3.8 Red cell indices in the full blood count, |
|
|
69 | (3) |
|
3.9 Morphology of the red cell, |
|
|
72 | (2) |
|
|
74 | (1) |
|
|
74 | (1) |
4 The Pathology of the Red Blood Cell, |
|
75 | (34) |
|
4.1 Introduction: diseases of red cells, |
|
|
75 | (3) |
|
4.2 Anaemia resulting from attack on, or stress to, the bone marrow, |
|
|
78 | (2) |
|
4.3 Anaemia due to deficiency, |
|
|
80 | (5) |
|
4.4 Intrinsic defects in the red cell, |
|
|
85 | (15) |
|
4.5 External factors acting on healthy cells, |
|
|
100 | (3) |
|
4.6 Erythrocytosis and polycythaemia, |
|
|
103 | (2) |
|
4.7 Molecular genetics and red cell disease, |
|
|
105 | (1) |
|
|
105 | (1) |
|
|
105 | (2) |
|
|
107 | (1) |
|
|
107 | (1) |
|
|
107 | (2) |
5 White Blood Cells in Health and Disease, |
|
109 | (26) |
|
|
109 | (2) |
|
|
111 | (4) |
|
|
115 | (1) |
|
|
116 | (1) |
|
|
117 | (1) |
|
|
118 | (1) |
|
|
119 | (1) |
|
5.8 Leukocytes in action, |
|
|
120 | (7) |
|
5.9 White cells in clinical medicine, |
|
|
127 | (5) |
|
|
132 | (1) |
|
|
132 | (1) |
|
|
133 | (2) |
6 White Blood Cell Malignancy, |
|
135 | (26) |
|
6.1 The genetic basis of leukocyte malignancy, |
|
|
135 | (4) |
|
6.2 Tissue techniques in haemato-oncology, |
|
|
139 | (2) |
|
|
141 | (8) |
|
|
149 | (3) |
|
6.5 Myeloma and related conditions, |
|
|
152 | (5) |
|
6.6 Myelofibrosis and myelodysplasi4, |
|
|
157 | (1) |
|
|
157 | (1) |
|
|
158 | (1) |
|
|
159 | (1) |
|
|
159 | (2) |
7 The Physiology and Pathology of Haemostasis, |
|
161 | (16) |
|
7.1 The blood-vessel wall, |
|
|
162 | (1) |
|
|
163 | (2) |
|
7.3 The coagulation pathway, |
|
|
165 | (3) |
|
7.4 Haemostasis as the balance between thrombus formation and removal, |
|
|
168 | (3) |
|
7.5 The haemostasis laboratory, |
|
|
171 | (2) |
|
7.6 The pathology of thrombosis, |
|
|
173 | (2) |
|
|
175 | (1) |
|
|
175 | (2) |
8 The Diagnosis and Management of Disorders of Haemostasis, |
|
177 | (32) |
|
8.1 Thrombosis 1: overactive platelets and thrombocytosis, |
|
|
177 | (4) |
|
8.2 Thrombosis 2: overactive coagulation, |
|
|
181 | (12) |
|
8.3 Haemorrhage 1: platelet underactivity and thrombocytopenia, |
|
|
193 | (6) |
|
8.4 Haemorrhage 2: coagulation underactivity, |
|
|
199 | (4) |
|
8.5 Disseminated intravascular coagulation, |
|
|
203 | (1) |
|
8.6 Molecular genetics in haemostasis, |
|
|
204 | (1) |
|
|
205 | (1) |
|
|
206 | (1) |
|
|
206 | (1) |
|
|
207 | (1) |
|
|
207 | (1) |
|
|
207 | (2) |
9 Immunopathology, |
|
209 | (32) |
|
|
209 | (1) |
|
9.2 Basics of the immune system, |
|
|
210 | (2) |
|
|
212 | (3) |
|
9.4 Immunopathology 1: immunodeficiency, |
|
|
215 | (6) |
|
9.5 Immunopathology 2: hypersensitivity, |
|
|
221 | (5) |
|
9.6 Immunopathology 3: autoimmune disease, |
|
|
226 | (6) |
|
|
232 | (2) |
|
9.8 The immunology laboratory, |
|
|
234 | (4) |
|
|
238 | (1) |
|
|
239 | (1) |
|
|
240 | (1) |
|
|
240 | (1) |
|
|
240 | (1) |
|
|
240 | (1) |
10 Immunogenetics and Histocompatibility, |
|
241 | (20) |
|
10.1 The genetics of antigen recognition, |
|
|
241 | (4) |
|
10.2 Human leukocyte antigens, |
|
|
245 | (6) |
|
|
251 | (6) |
|
10.4 Autoimmunity and human leukocyte antigens, |
|
|
257 | (3) |
|
|
260 | (1) |
|
|
260 | (1) |
|
|
260 | (1) |
|
|
260 | (1) |
11 Blood Transfusion, |
|
261 | (26) |
|
11.1 Blood collection and processing, |
|
|
262 | (3) |
|
|
265 | (8) |
|
11.3 Laboratory practice of blood transfusion, |
|
|
273 | (6) |
|
11.4 Clinical practice of blood transfusion, |
|
|
279 | (2) |
|
11.5 Hazards of blood transfusion, |
|
|
281 | (3) |
|
|
284 | (1) |
|
|
284 | (1) |
|
|
284 | (1) |
|
|
284 | (1) |
|
|
285 | (2) |
12 Waste Products, Electrolytes and Renal Disease, |
|
287 | (18) |
|
12.1 Renal anatomy and physiology, |
|
|
287 | (1) |
|
|
288 | (7) |
|
|
295 | (2) |
|
12.4 Renal endocrinology, |
|
|
297 | (1) |
|
|
298 | (3) |
|
|
301 | (2) |
|
|
303 | (1) |
|
|
303 | (1) |
|
|
303 | (1) |
|
|
303 | (2) |
13 Hydrogen Ions, pH, and Acid-Base Disorders, |
|
305 | (14) |
|
|
305 | (3) |
|
|
308 | (4) |
|
|
312 | (1) |
|
13.4 Alkalosis (pH >7.5), |
|
|
313 | (1) |
|
13.5 Mixed acid-base conditions, |
|
|
314 | (1) |
|
13.6 Clinical interpretation, |
|
|
314 | (1) |
|
|
315 | (1) |
|
|
316 | (1) |
|
|
317 | (1) |
|
|
317 | (2) |
14 Glucose, Lipids and Atherosclerosis, |
|
319 | (32) |
|
|
319 | (14) |
|
|
333 | (10) |
|
|
343 | (4) |
|
|
347 | (1) |
|
|
348 | (1) |
|
|
348 | (1) |
|
|
349 | (1) |
|
|
349 | (2) |
15 Calcium, Phosphate, Magnesium and Bone Disease, |
|
351 | (20) |
|
|
352 | (3) |
|
|
355 | (1) |
|
|
355 | (1) |
|
|
355 | (2) |
|
15.5 Disorders of calcium homeostasis, |
|
|
357 | (3) |
|
15.6 Disorders of phosphate homeostasis, |
|
|
360 | (2) |
|
15.7 Disorders of magnesium homeostasis, |
|
|
362 | (1) |
|
|
363 | (1) |
|
|
364 | (4) |
|
|
368 | (1) |
|
|
369 | (1) |
|
|
370 | (1) |
|
|
370 | (1) |
|
|
370 | (1) |
16 Nutrients and Gastrointestinal Disorders, |
|
371 | (12) |
|
|
371 | (4) |
|
|
375 | (6) |
|
|
381 | (1) |
|
|
382 | (1) |
|
|
382 | (1) |
|
|
382 | (1) |
17 Liver Function Tests and Plasma Proteins, |
|
383 | (24) |
|
17.1 Anatomy and physiology of the liver, |
|
|
384 | (5) |
|
17.2 Liver function tests, |
|
|
389 | (1) |
|
17.3 Diseases of the liver, |
|
|
390 | (6) |
|
|
396 | (9) |
|
|
405 | (1) |
|
|
406 | (1) |
|
|
406 | (1) |
|
|
406 | (1) |
18 Hormones and Endocrine Disorders, |
|
407 | (30) |
|
18.1 Endocrine physiology, |
|
|
407 | (10) |
|
18.2 The pathology of the endocrine system, |
|
|
417 | (17) |
|
|
434 | (1) |
|
|
435 | (1) |
|
|
435 | (1) |
|
|
436 | (1) |
19 Cancer and Tumour Markers, |
|
437 | (12) |
|
19.1 General concepts in cancer biology, |
|
|
437 | (3) |
|
19.2 Blood science and cancer, |
|
|
440 | (4) |
|
|
444 | (1) |
|
|
445 | (1) |
|
|
446 | (1) |
|
|
446 | (1) |
|
|
447 | (1) |
|
|
447 | (2) |
20 Inherited Metabolic Disorders, |
|
449 | (10) |
|
20.1 The genetics of inheritance, |
|
|
449 | (2) |
|
20.2 Molecular inherited metabolic disorders, |
|
|
451 | (4) |
|
20.3 Organelle inherited metabolic disorders, |
|
|
455 | (1) |
|
20.4 Antenatal diagnosis and neonatal screening, |
|
|
455 | (1) |
|
|
456 | (1) |
|
|
457 | (1) |
|
|
457 | (2) |
21 Drugs and Poisons, |
|
459 | (12) |
|
|
459 | (2) |
|
21.2 Toxicology of specific compounds, |
|
|
461 | (4) |
|
21.3 Therapeutic drug monitoring, |
|
|
465 | (3) |
|
|
468 | (1) |
|
|
469 | (1) |
|
|
469 | (1) |
|
|
469 | (2) |
22 Case Reports in Blood Science, |
|
471 | (20) |
|
|
471 | (1) |
|
|
472 | (1) |
|
Anaemia, hypercalcaemia, proteinuria, myeloma |
|
|
|
|
473 | (1) |
|
Diabetes, glycated haemoglobin, chronic renal failure |
|
|
|
|
474 | (1) |
|
Acute kidney injury, leucocytosis, neutrophilia, viruses |
|
|
|
|
475 | (2) |
|
Part 1: Obesity, colorectal cancer, CEA, hypothyroidism. Part 2: Alcoholism, raised GGT and triacylglycerols |
|
|
|
|
477 | (2) |
|
Part 1: No abnormalities. Part 2: Asthma, raised IgE. Part 3: Falling haemoglobin, rising ESR, lung cancer |
|
|
|
|
479 | (1) |
|
Hypothyroidism, marginally reduced haemoglobin |
|
|
|
|
480 | (1) |
|
Raised CRP, ESR, rheumatoid factor and anti-nuclear antibodies; borderline anti-dsDNA antibodies, low C3, low eGFR and so mild renal failure, systemic lupus erythematosus |
|
|
|
|
481 | (1) |
|
Normal blood results in renal transplantation |
|
|
|
|
482 | (2) |
|
Falling albumin, eGFR, haemoglobin, red cell count and platelets, rising ESR, white cell count and neutrophila, CRP, urea and creatinine, septicaemia |
|
|
|
|
484 | (2) |
|
Microcytic anaemia, thrombocytopenia, lymphocytosis, abnormal LFTs, falling albumin, raised CRP, myositis with raised CK, viruses |
|
|
|
|
486 | (1) |
|
Acidosis, hyperglycaemia, diabetic ketoacidosis, acute renal injury, raised urea and creatinine |
|
|
|
|
487 | (1) |
|
Low haemoglobin, thrombocytopenia, raised CRP and d-dimers, abnormal LFTs, malaria, pregnancy |
|
|
|
|
488 | (1) |
|
Raised aldosterone, hypernatraemia, hypokalaemia, Conn's syndrome |
|
|
|
|
489 | (1) |
|
Paediatric diabetic ketoacidosis, hyperglycaemia, low bicarbonate, raised phosphates, ALP and proteins |
|
|
|
|
490 | (1) |
Appendix: Reference Ranges, |
|
491 | (2) |
Further Reading, |
|
493 | (2) |
Glossary, |
|
495 | (24) |
Index, |
|
519 | |